Antibiotic resistance is taking its toll on the pharmaceutical industry: Drugs are getting retired from clinical circulation, because many are starting to get rendered ineffective, according to an article from Washington University of St. Louis. It highlights the work of WUSTL’s Michael Kinch, associated vice chancellor of its Center for Research Innovation in Business:
{iframe}http://medcitynews.com/2014/10/drug-companies-slowly-retiring-antibiotic-antibiotic/{/iframe}